Oncogenerix - Ownership and Business Overview

Life ScienceCompany

Oncogenerix Ownership

Who owns Oncogenerix?

Oncogenerix is owned by DARA BioSciences. It was acquired on January 17, 2012.

Oncogenerix Business Overview

Where is Oncogenerix headquartered?

Oncogenerix is headquartered in Mount Pleasant, South Carolina.

What sector is Oncogenerix in?

Oncogenerix is a life science company.

Life Science M&A Summary in 2012

Out of 60 sectors in the Mergr database, life science ranked 18 in number of deals in 2012. The largest life science acquisition in 2012 was Amylin Pharmaceuticals - which was acquired by Bristol-Myers Squibb for $5.3B.

Join Mergr to view all 124 acquisitions of life science companies in 2012, including 18 acquisitions by private equity firms, and 106 by strategics.

Oncogenerix, Inc.

3069 Pionalelli Crescent,
Mount Pleasant, South Carolina 29466
United States,
www.oncogenerixpharma.com

Oncogenerix, Inc. is a specialty pharmaceutical company.


 Subscribe to unlock this and 203,188
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 195K M&A Transactions
  • 199K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.